Education
About Us
Working with TipRanks
Follow Us
Ibio Inc (IBIO)
:IBIO
IBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.64 - $6.89
Previous CloseN/A
Volume55.53K
Average Volume (3M)701.80K
Market Cap
$17.01M
Enterprise Value$195.14M
Total Cash (Recent Filing)$4.96M
Total Debt (Recent Filing)$2.93M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Sep 30, 2025EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.49
Shares Outstanding16,519,281
10 Day Avg. Volume570,960
30 Day Avg. Volume701,797
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)70.92
Price to Sales (P/S)0.00
P/FCF Ratio-11.67
Enterprise Value/Market Cap11.47
Enterprise Value/Revenue169.69
Enterprise Value/Gross Profit174.39
Enterprise Value/Ebitda-3.55
Forecast
1Y Price Target
$6.00Price Target Upside545.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Ibio News
PremiumCompany Announcements
iBio, Inc. Reports Strong Q3 2025 Progress
PremiumCompany Announcements
iBio Enters Licensing Agreement for Obesity Treatment
PremiumCompany Announcements
iBio Highlights Advancements in Obesity Antibody ProgramsOptions Prices
Currently, No data available
---
Ownership Overview
1.54% Insiders
0.97% Mutual Funds
12.61% Other Institutional Investors
84.04% Public Companies and Individual Investors
IBIO FAQ
What was Ibio Inc’s price range in the past 12 months?
Ibio Inc lowest stock price was $0.64 and its highest was $6.89 in the past 12 months.
What is Ibio Inc’s market cap?
Ibio Inc’s market cap is $17.01M.
When is Ibio Inc’s upcoming earnings report date?
Ibio Inc’s upcoming earnings report date is Sep 30, 2025 which is in 107 days.
How were Ibio Inc’s earnings last quarter?
Ibio Inc released its earnings results on May 02, 2025. The company reported -$0.49 earnings per share for the quarter, missing the consensus estimate of -$0.32 by -$0.17.
Is Ibio Inc overvalued?
According to Wall Street analysts Ibio Inc’s price is currently Undervalued.
Does Ibio Inc pay dividends?
Ibio Inc does not currently pay dividends.
What is Ibio Inc’s EPS estimate?
Ibio Inc’s EPS estimate is -0.34.
How many shares outstanding does Ibio Inc have?
Ibio Inc has 16,519,281 shares outstanding.
What happened to Ibio Inc’s price movement after its last earnings report?
Ibio Inc reported an EPS of -$0.49 in its last earnings report, missing expectations of -$0.32. Following the earnings report the stock price went down -1.942%.
Which hedge fund is a major shareholder of Ibio Inc?
Currently, no hedge funds are holding shares in IBIO
Ibio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (545.16% Upside)
$6.00 (545.16% Upside)
Blogger Sentiment
Bearish
IBIO Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $655.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 3.3%
Last 30 Days ▲ 5.2%
Last 30 Days ▲ 5.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.89%
12-Months-Change
Fundamentals
Return on Equity
-90.83%
Trailing 12-Months
Asset Growth
-61.91%
Trailing 12-Months
Company Description
Ibio Inc
iBio, Inc. is a biotechnology company that focuses on developing plant-based biologics for the biopharmaceutical market. The company operates primarily in the sectors of biopharmaceutical development and manufacturing, utilizing its proprietary FastPharming System to produce vaccines and therapeutic proteins. iBio aims to provide more efficient and cost-effective solutions for biologics production, targeting areas such as oncology, fibrosis, and infectious diseases.